Results oncology partial nephrectomy for renal cell carcinoma 4 cm multifocal

UroToday – the only urology website with original content written by key opinion leaders actively engaged in clinical practice global urology. To access the latest urology news releases UroToday, go to: www.urotoday.comManagement of patients with multifocal renal tumors, and hereditary syndromes that predispose to the formation of renal cell carcinoma is a challenge. To avoid the repeated interventions of the kidney surgical morbidity, and reduce the likelihood of developing metastatic disease, an approach was developed in this patient population to recommend surgical removal of kidney cancer with partial nephrectomy when the tumor reaches more than 3 cm . However, despite aggressive screening, some of these patients have large tumors because of late diagnosis or comorbidity. Although recent data have shown that partial nephrectomy for T1b tumors and cancer equivalent to a radical nephrectomy and may also confer a survival advantage in the population sparse, to our knowledge, no study has evaluated the results of clinical oncology for T1b renal masses in the presence of multifocal disease.

These results show that we must be careful at this time, the first Alzheimer’s disease is diagnosed when people have just started to have problems forgetting things, said study author Robert S. Wilson, Ph.D., of Rush University Medical Center in Chicago

Written by N. Gopal Gupta, MD as part of Beyond the Abstract on UroToday. This initiative offers a method of publishing for the professional community urology. The authors have the opportunity to expand the circumstances, limitations, etc., of their research by referencing the published abstract.